26
|
Uno T, Wada K, Matsuda S, Ikura M, Takenaka H, Terakawa N, Oita A, Yokoyama S, Kawase A, Hosomi K, Takada M. Clotrimazole troches can alter everolimus pharmacokinetics in post-transplant patients: A case report. Br J Clin Pharmacol 2019; 85:2176-2178. [PMID: 31243774 DOI: 10.1111/bcp.14017] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2019] [Revised: 05/10/2019] [Accepted: 05/17/2019] [Indexed: 11/30/2022] Open
|
27
|
Hosomi K, Mori N, Mano T, Kishima H, Saitoh Y. Exploratory study of optimal conditions of repetitive transcranial magnetic stimulation of the primary motor cortex for chronic pain. Brain Stimul 2019. [DOI: 10.1016/j.brs.2018.12.474] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
28
|
Hosomi K, Fujimoto M, Ushio K, Mao L, Kato J, Takada M. An integrative approach using real-world data to identify alternative therapeutic uses of existing drugs. PLoS One 2018; 13:e0204648. [PMID: 30300381 PMCID: PMC6177143 DOI: 10.1371/journal.pone.0204648] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2018] [Accepted: 09/12/2018] [Indexed: 12/14/2022] Open
Abstract
Different computational approaches are employed to efficiently identify novel repositioning possibilities utilizing different sources of information and algorithms. It is critical to propose high-valued candidate-repositioning possibilities before conducting lengthy in vivo validation studies that consume significant resources. Here we report a novel multi-methodological approach to identify opportunities for drug repositioning. We performed analyses of real-world data (RWD) acquired from the United States Food and Drug Administration’s Adverse Event Reporting System (FAERS) and the claims database maintained by the Japan Medical Data Center (JMDC). These analyses were followed by cross-validation through bioinformatics analyses of gene expression data. Inverse associations revealed using disproportionality analysis (DPA) and sequence symmetry analysis (SSA) were used to detect potential drug-repositioning signals. To evaluate the validity of the approach, we conducted a feasibility study to identify marketed drugs with the potential for treating inflammatory bowel disease (IBD). Primary analyses of the FAERS and JMDC claims databases identified psycholeptics such as haloperidol, diazepam, and hydroxyzine as candidates that may improve the treatment of IBD. To further investigate the mechanistic relevance between hit compounds and disease pathology, we conducted bioinformatics analyses of the associations of the gene expression profiles of these compounds with disease. We identified common biological features among genes differentially expressed with or without compound treatment as well as disease-perturbation data available from open sources, which strengthened the mechanistic rationale of our initial findings. We further identified pathways such as cytokine signaling that are influenced by these drugs. These pathways are relevant to pathologies and can serve as alternative targets of therapy. Integrative analysis of RWD such as those available from adverse-event databases, claims databases, and transcriptome analyses represent an effective approach that adds value to efficiently identifying potential novel therapeutic opportunities.
Collapse
|
29
|
Yang SB, Ahn JK, Akazawa Y, Aoki K, Chiga N, Ekawa H, Evtoukhovitch P, Feliciello A, Fujita M, Hasegawa S, Hayakawa S, Hayakawa T, Honda R, Hosomi K, Hwang SH, Ichige N, Ichikawa Y, Ikeda M, Imai K, Ishimoto S, Kanatsuki S, Kim SH, Kinbara S, Kobayashi K, Koike T, Lee JY, Miwa K, Moon TJ, Nagae T, Nakada Y, Nakagawa M, Ogura Y, Sakaguchi A, Sako H, Sasaki Y, Sato S, Shirotori K, Sugimura H, Suto S, Suzuki S, Takahashi T, Tamura H, Tanida K, Togawa Y, Tsamalaidze Z, Ukai M, Wang TF, Yamamoto TO. First Determination of the Level Structure of an sd-Shell Hypernucleus, _{Λ}^{19}F. PHYSICAL REVIEW LETTERS 2018; 120:132505. [PMID: 29694189 DOI: 10.1103/physrevlett.120.132505] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/20/2017] [Revised: 02/15/2018] [Indexed: 06/08/2023]
Abstract
We report on the first observation of γ rays emitted from an sd-shell hypernucleus, _{Λ}^{19}F. The energy spacing between the ground state doublet, 1/2^{+} and 3/2^{+} states, of _{Λ}^{19}F is determined to be 315.5±0.4(stat)_{-0.5}^{+0.6}(syst) keV by measuring the γ-ray energy of the M1(3/2^{+}→1/2^{+}) transition. In addition, three γ-ray peaks are observed and assigned as E2(5/2^{+}→1/2^{+}), E1(1/2^{-}→1/2^{+}), and E1(1/2^{-}→3/2^{+}) transitions. The excitation energies of the 5/2^{+} and 1/2^{-} states are determined to be 895.2±0.3(stat)±0.5(syst) and 1265.6±1.2(stat)_{-0.5}^{+0.7}(syst) keV, respectively. It is found that the ground state doublet spacing is well described by theoretical models based on existing s- and p-shell hypernuclear data.
Collapse
|
30
|
Yokoyama S, Tanaka Y, Nakagita K, Hosomi K, Takada M. Bleeding Risk of Warfarin and Direct Oral Anticoagulants in Younger Population: A Historical Cohort Study Using a Japanese Claims Database. Int J Med Sci 2018; 15:1686-1693. [PMID: 30588192 PMCID: PMC6299405 DOI: 10.7150/ijms.28877] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/31/2018] [Accepted: 09/14/2018] [Indexed: 12/18/2022] Open
Abstract
A historical cohort analysis of the Japan medical data center (JMDC) claims databases was performed to compare the incidence rates of bleeding events with warfarin (WF) versus direct oral anticoagulant (DOAC) treatment in patients with non-valvular atrial fibrillation. The aim of this study is to clarify the risk factors for bleeding events in younger patients newly treated with WF or DOAC in clinical practice setting. Patients who newly initiated WF or DOAC treatment from April 2012 to March 2015 were selected from the JMDC claims database. A 1:1 propensity score matching analysis was used for new users of WF or DOAC. Kaplan-Meier curves were generated to depict the time to bleeding event (total bleeding events, gastrointestinal hemorrhage, and intracranial hemorrhage) during the follow-up period. Cox proportional regression models were used to estimate the hazard ratios for total bleeding events caused by oral anticoagulants. Overall, 2,046 patients (503 WF and 1,543 DOAC) were included. After applying propensity score matching, Kaplan-Meier analysis of the WF and DOAC groups displayed comparable incidences of total bleeding events, gastrointestinal hemorrhage, and intracranial hemorrhage. Cox proportional hazards modeling showed that the use of WF was not associated with total bleeding events compared with DOAC (hazard ratio: 1.21, 95% confidence interval: 0.93-1.54, p = 0.15). This historical cohort study using a claims database indicates that the bleeding risk of DOAC was comparable to that of WF in Japanese younger population.
Collapse
|
31
|
Yamato M, Wada K, Hayashi T, Fujimoto M, Hosomi K, Oita A, Takada M. Association between Serum Amiodarone and N-Desethylamiodarone Concentrations and Development of Thyroid Dysfunction. Clin Drug Investig 2017; 38:39-48. [DOI: 10.1007/s40261-017-0582-4] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
|
32
|
Mukai Y, Wada K, Miyamoto K, Nakagita K, Fujimoto M, Hosomi K, Kuwahara T, Takada M, Kusano K, Oita A. The influence of residual apixaban on bleeding complications during and after catheter ablation of atrial fibrillation. J Arrhythm 2017; 33:434-439. [PMID: 29021846 PMCID: PMC5634723 DOI: 10.1016/j.joa.2017.06.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2017] [Revised: 03/14/2017] [Accepted: 06/22/2017] [Indexed: 11/29/2022] Open
Abstract
Background The periprocedural protocol for atrial fibrillation (AF) ablation commonly includes anticoagulation therapy. Apixaban, a direct oral anticoagulant, is currently approved for clinical use; however, little is known about the effects of residual apixaban concentration on bleeding complications during/after AF ablation. Therefore, we measured residual apixaban concentration by using mass spectrometry and examined the anticoagulant's residual effects on bleeding complications. Methods Fifty-eight patients (Mean age of 64.7±12.5 years; 31 males, 27 females) were enrolled and administered apixaban twice daily. We analyzed trough apixaban concentration, activated clotting time (ACT), heparin dose, and bleeding complications during/after AF ablation. Apixaban concentrations were directly measured using mass spectrometry. Results Bleeding complications were observed in 19 patients (delayed hemostasis at the puncture site, 16; hematuria, 3; hemosputum, 1). No patient required blood transfusion. The mean trough apixaban concentration was significantly lower in patients with bleeding complications than without (152.4±73.1 vs. 206.8±98.8 ng/mL respectively, P=0.037), while the heparin dose to achieve ACT>300 s was significantly higher in patients with bleeding complications (9368.4±2929.0 vs. 7987.2±2135.2 U/body respectively, P=0.046). Interestingly, a negative correlation was found between the trough apixaban concentration and the heparin dose to achieve ACT>300 s (P=0.033, R=-0.281). Conclusions Low residual plasma apixaban is associated with a higher incidence of bleeding complications during/after AF ablation, potentially because of a greater heparin requirement during AF ablation.
Collapse
|
33
|
Yanagisawa T, Fukuma R, Seymour B, Hosomi K, Kishima H, Yokoi H, Hirata M, Yoshimine T, Kamitani Y, Saitoh Y. S109 Magnetoencephalographic-based brain–machine interface robotic hand for controlling sensorimotor cortical plasticity and phantom limb pain. Clin Neurophysiol 2017. [DOI: 10.1016/j.clinph.2017.07.120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
34
|
Yamato M, Wada K, Fujimoto M, Hosomi K, Hayashi T, Oita A, Takada M. Association between N-desethylamiodarone/amiodarone ratio and amiodarone-induced thyroid dysfunction. Eur J Clin Pharmacol 2017; 73:289-296. [PMID: 28083650 DOI: 10.1007/s00228-017-2195-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2016] [Accepted: 01/04/2017] [Indexed: 01/17/2023]
Abstract
PURPOSE We used a retrospective data mining approach to explore the association between serum amiodarone (AMD) and N-desethylamiodarone (DEA) concentrations and thyroid-related hormone levels. METHODS Laboratory data sets from January 2012 to April 2016 were extracted from the computerized hospital information system database at the National Cerebral and Cardiovascular Center (NCVC). Data sets that contained serum AMD and DEA concentrations and thyroid function tests, including thyroid-stimulating hormone (TSH), free thyroxine (FT4), and free triiodothyronine (FT3), were analyzed. RESULTS A total of 1831 clinical laboratory data sets from 330 patients were analyzed. Data sets were classified into five groups (euthyroidism, hyperthyroidism, subclinical hyperthyroidism, hypothyroidism, and subclinical hypothyroidism) based on the definition of thyroid function in our hospital. Most abnormal levels of thyroid hormones were observed within the therapeutic range of serum AMD and DEA concentrations. The mean DEA/AMD ratio in the hyperthyroidism group was significantly higher than that in the euthyroidism group (0.95 ± 0.42 vs. 0.87 ± 0.28, p = 0.0209), and the mean DEA/AMD ratio in the hypothyroidism group was significantly lower than that in the euthyroidism group (0.77 ± 0.26 vs. 0.87 ± 0.28, p = 0.0038). The suppressed TSH group (0.98 ± 0.41 vs. 0.87 ± 0.28, p < 0.001) and the elevated FT4 level group (0.90 ± 0.33 vs. 0.84 ± 0.27, p = 0.0037) showed significantly higher DEA/AMD ratios compared with normal level groups. The elevated TSH group showed a significantly lower DEA/AMD ratio compared with the normal group (0.81 ± 0.25 vs. 0.87 ± 0.28, p < 0.0001). CONCLUSIONS High and low DEA/AMD ratios were associated with AMD-induced hyperthyroidism and hypothyroidism, respectively. The DEA/AMD ratio may be a predictive marker for AMD-induced thyroid dysfunction.
Collapse
|
35
|
Kinoshita S, Hayashi T, Wada K, Yamato M, Kuwahara T, Anzai T, Fujimoto M, Hosomi K, Takada M. Risk factors for amiodarone-induced thyroid dysfunction in Japan. J Arrhythm 2016; 32:474-480. [PMID: 27920832 PMCID: PMC5129120 DOI: 10.1016/j.joa.2016.03.008] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2015] [Revised: 03/15/2016] [Accepted: 03/24/2016] [Indexed: 11/24/2022] Open
Abstract
Background Amiodarone is associated with a number of significant adverse effects, including elevated transaminase levels, pulmonary fibrosis, arrhythmia, and thyroid dysfunction. Although thyroid dysfunction is considered to be a common and potentially serious adverse effect of amiodarone therapy, the exact pathogenesis remains unknown because of its complex manifestations. Therefore, the prevalence of, and risk factors for, amiodarone-induced thyroid dysfunction in Japanese patients were investigated in the present study. Methods A retrospective analysis of patients treated with amiodarone between January 2012 and December 2013 was performed. A total of 317 patients with euthyroidism, or subclinical hyperthyroidism or hypothyroidism, were enrolled in this study. Results After being treated with amiodarone, 30 (9.5%) and 60 patients (18.9%) developed amiodarone-induced hyperthyroidism and amiodarone-induced hypothyroidism, respectively. Ten (33.3%) patients with amiodarone-induced hyperthyroidism and 40 (66.6%) with amiodarone-induced hypothyroidism were diagnosed within two years of the initiation of amiodarone therapy. Dilated cardiomyopathy (DCM) [Adjusted odds ratio (OR) 3.30 (95% confidence interval (CI): 1.26–8.90)], and cardiac sarcoidosis [Adjusted OR 6.47 (95% CI: 1.60–25.77)] were identified as predictors of amiodarone-induced hyperthyroidism. The baseline free thyroxine (T4) level [Adjusted OR 0.13 (95% CI: 0.03–0.68)], and thyroid-stimulating hormone (TSH) level [Adjusted OR1.47 (95% CI: 1.26–1.74)] were identified as predictors of amiodarone-induced hypothyroidism. Conclusion DCM and cardiac sarcoidosis were identified as risk factors for amiodarone-induced hyperthyroidism. Risk factors for amiodarone-induced hypothyroidism included higher baseline TSH level and lower baseline free T4 level, suggesting that subclinical hypothyroidism may be a potential risk factor for the development of amiodarone-induced hypothyroidism.
Collapse
|
36
|
Saitoh Y, Hosomi K, Nakamura H, Shimizu T. The Japanese rTMS experience – Present and future. Clin Neurophysiol 2016. [DOI: 10.1016/j.clinph.2015.11.122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
37
|
Shimizu T, Maruo T, Hosomi K, Goto Y, Yokoe M, Kageyama Y, Yanagisawa T, Oshino S, Kishima H, Yoshimine T, Saitoh Y. Efficacy of repetitive transcranial stimulation with H-coil for treatment of intractable neuropathic pain in lower extremities. Clin Neurophysiol 2016. [DOI: 10.1016/j.clinph.2015.11.089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
38
|
Takada M, Fujimoto M, Hosomi K. Association between Benzodiazepine Use and Dementia: Data Mining of Different Medical Databases. Int J Med Sci 2016; 13:825-834. [PMID: 27877074 PMCID: PMC5118753 DOI: 10.7150/ijms.16185] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/16/2016] [Accepted: 09/27/2016] [Indexed: 01/01/2023] Open
Abstract
Purpose: Some studies have suggested that the use of benzodiazepines in the elderly is associated with an increased risk of dementia. However, this association might be due to confounding by indication and reverse causation. To examine the association between benzodiazepine anxiolytic drug use and the risk of dementia, we conducted data mining of a spontaneous reporting database and a large organized database of prescriptions. Methods: Data from the US Food and Drug Administration Adverse Event Reporting System (FAERS) from the first quarter of 2004 through the end of 2013 and data from the Canada Vigilance Adverse Reaction Online Database from the first quarter of 1965 through the end of 2013 were used for the analyses. The reporting odds ratio (ROR) and information component (IC) were calculated. In addition, prescription sequence symmetry analysis (PSSA) was performed to identify the risk of dementia after using benzodiazepine anxiolytic drugs over the period of January 2006 to May 2014. Results: Benzodiazepine use was found to be associated with dementia in analyses using the FAERS database (ROR: 1.63, 95% CI: 1.61-1.64; IC: 0.66, 95% CI: 0.65-0.67) and the Canada Vigilance Adverse Reaction Online Database (ROR: 1.88, 95% CI: 1.83-1.94; IC: 0.85, 95% CI: 0.80-0.89). ROR and IC values increased with the duration of action of benzodiazepines. In the PSSA, a significant association was found, with adjusted sequence ratios of 1.24 (1.05-1.45), 1.20 (1.06-1.37), 1.23 (1.11-1.37), 1.34 (1.23-1.47), 1.41 (1.29-1.53), and 1.44 (1.33-1.56) at intervals of 3, 6, 12, 24, 36, and 48 months, respectively. Furthermore, the additional PSSA, in which patients who initiated a new treatment with benzodiazepines and anti-dementia drugs within 12- and 24-month periods were excluded from the analysis, demonstrated significant associations of benzodiazepine use with dementia risk. Conclusion: Multi-methodological approaches using different methods, algorithms, and databases suggest that long-term use of benzodiazepines and long-acting benzodiazepines are strongly associated with an increased risk of dementia.
Collapse
|
39
|
Takada M, Fujimoto M, Motomura H, Hosomi K. Inverse Association between Sodium Channel-Blocking Antiepileptic Drug Use and Cancer: Data Mining of Spontaneous Reporting and Claims Databases. Int J Med Sci 2016; 13:48-59. [PMID: 26816494 PMCID: PMC4716819 DOI: 10.7150/ijms.13834] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/13/2015] [Accepted: 11/27/2015] [Indexed: 11/05/2022] Open
Abstract
PURPOSE Voltage-gated sodium channels (VGSCs) are drug targets for the treatment of epilepsy. Recently, a decreased risk of cancer associated with sodium channel-blocking antiepileptic drugs (AEDs) has become a research focus of interest. The purpose of this study was to test the hypothesis that the use of sodium channel-blocking AEDs are inversely associated with cancer, using different methodologies, algorithms, and databases. METHODS A total of 65,146,507 drug-reaction pairs from the first quarter of 2004 through the end of 2013 were downloaded from the US Food and Drug Administration Adverse Event Reporting System. The reporting odds ratio (ROR) and information component (IC) were used to detect an inverse association between AEDs and cancer. Upper limits of the 95% confidence interval (CI) of < 1 and < 0 for the ROR and IC, respectively, signified inverse associations. Furthermore, using a claims database, which contains 3 million insured persons, an event sequence symmetry analysis (ESSA) was performed to identify an inverse association between AEDs and cancer over the period of January 2005 to May 2014. The upper limit of the 95% CI of adjusted sequence ratio (ASR) < 1 signified an inverse association. RESULTS In the FAERS database analyses, significant inverse associations were found between sodium channel-blocking AEDs and individual cancers. In the claims database analyses, sodium channel-blocking AED use was inversely associated with diagnoses of colorectal cancer, lung cancer, gastric cancer, and hematological malignancies, with ASRs of 0.72 (95% CI: 0.60 - 0.86), 0.65 (0.51 - 0.81), 0.80 (0.65 - 0.98), and 0.50 (0.37 - 0.66), respectively. Positive associations between sodium channel-blocking AEDs and cancer were not found in the study. CONCLUSION Multi-methodological approaches using different methodologies, algorithms, and databases suggest that sodium channel-blocking AED use is inversely associated with colorectal cancer, lung cancer, gastric cancer, and hematological malignancies.
Collapse
|
40
|
Yamamoto TO, Agnello M, Akazawa Y, Amano N, Aoki K, Botta E, Chiga N, Ekawa H, Evtoukhovitch P, Feliciello A, Fujita M, Gogami T, Hasegawa S, Hayakawa SH, Hayakawa T, Honda R, Hosomi K, Hwang SH, Ichige N, Ichikawa Y, Ikeda M, Imai K, Ishimoto S, Kanatsuki S, Kim MH, Kim SH, Kinbara S, Koike T, Lee JY, Marcello S, Miwa K, Moon T, Nagae T, Nagao S, Nakada Y, Nakagawa M, Ogura Y, Sakaguchi A, Sako H, Sasaki Y, Sato S, Shiozaki T, Shirotori K, Sugimura H, Suto S, Suzuki S, Takahashi T, Tamura H, Tanabe K, Tanida K, Tsamalaidze Z, Ukai M, Yamamoto Y, Yang SB. Observation of Spin-Dependent Charge Symmetry Breaking in ΛN Interaction: Gamma-Ray Spectroscopy of _{Λ}^{4}He. PHYSICAL REVIEW LETTERS 2015; 115:222501. [PMID: 26650298 DOI: 10.1103/physrevlett.115.222501] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/12/2015] [Indexed: 06/05/2023]
Abstract
The energy spacing between the spin-doublet bound state of _{Λ}^{4}He(1^{+},0^{+}) was determined to be 1406±2±2 keV, by measuring γ rays for the 1^{+}→0^{+} transition with a high efficiency germanium detector array in coincidence with the ^{4}He(K^{-},π^{-})_{Λ}^{4}He reaction at J-PARC. In comparison to the corresponding energy spacing in the mirror hypernucleus _{Λ}^{4}H, the present result clearly indicates the existence of charge symmetry breaking (CSB) in ΛN interaction. By combining the energy spacings with the known ground-state binding energies, it is also found that the CSB effect is large in the 0^{+} ground state but is vanishingly small in the 1^{+} excited state, demonstrating that the ΛN CSB interaction has spin dependence.
Collapse
|
41
|
Fujimoto M, Higuchi T, Hosomi K, Takada M. Association between statin use and cancer: data mining of a spontaneous reporting database and a claims database. Int J Med Sci 2015; 12:223-33. [PMID: 25678839 PMCID: PMC4323360 DOI: 10.7150/ijms.10656] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/27/2014] [Accepted: 01/07/2015] [Indexed: 01/08/2023] Open
Abstract
PURPOSE In recent years, the potential risk of cancer associated with statin use has been a focus of much interest. However, it remains uncertain whether statin therapy is associated with cancer risk. To examine the association between statin use and the risk of cancer, we conducted data mining using the US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) and a large organized database of claims constructed by a database vendor (The Japan Medical Data Center Co., Ltd, Tokyo, Japan [JMDC]). METHODS Relevant reports in the FAERS, which included data from the first quarter of 2004 through the end of 2012, were identified and analyzed. The reporting odds ratio (ROR) was used to detect spontaneous report signals and was calculated using the case/non-case method. Additionally, signals were detected via the information component (IC) using the IC025 metric. Furthermore, event sequence symmetry analysis (ESSA) was applied to identify the risk of cancer following treatment with statins over the period January 2005 to July 2013. RESULTS In the FAERS database analyses, significant signals for colorectal cancer and pancreatic cancer were found for statins as a class. In the ESSA, significant associations between statin use and colorectal cancer and pancreatic cancer were found, with adjusted sequence ratios (95% confidence intervals) of 1.20 (1.08-1.34) and 1.31 (1.13-1.53), respectively, at an interval of 48 months. CONCLUSIONS Multi-methodological approaches using different algorithms and databases suggest that statin use is associated with an increased risk for colorectal cancer and pancreatic cancer.
Collapse
|
42
|
Takada M, Fujimoto M, Yamazaki K, Takamoto M, Hosomi K. Association of Statin Use with Sleep Disturbances: Data Mining of a Spontaneous Reporting Database and a Prescription Database. Drug Saf 2014; 37:421-31. [DOI: 10.1007/s40264-014-0163-x] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
|
43
|
Sugimura H, Agnello M, Ahn J, Ajimura S, Akazawa Y, Amano N, Aoki K, Bhang H, Endo M, Evtoukhovitch P, Feliciello A, Fujioka H, Fukuda T, Hasegawa S, Hayakawa S, Honda R, Hosomi K, Hwang S, Ichikawa Y, Igarashi Y, Imai K, Ishibashi N, Iwasaki R, Joo C, Kiuchi R, Lee J, Lee J, Matsuda K, Matsumoto Y, Matsuoka K, Miwa K, Mizoi Y, Moritsu M, Nagae T, Nagamiya S, Nakagawa M, Naruki M, Noumi H, Ota R, Roy B, Saha P, Sakaguchi A, Sako H, Samanta C, Samoilov V, Sasaki Y, Sato S, Sekimoto M, Shimizu Y, Shiozaki T, Shirotori K, Soyama T, Takahashi T, Takahashi T, Tamura H, Tanabe K, Tanaka T, Tanida K, Tokiyasu A, Tsamalaidze Z, Ukai M, Yamamoto T, Yamamoto Y, Yang S, Yoshida K. Study onΛ6H hypernucleus by the (π−,K+) reaction at J-PARC. EPJ WEB OF CONFERENCES 2014. [DOI: 10.1051/epjconf/20146609017] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
44
|
Shirotori K, Takahashi TN, Adachi S, Agnello M, Ajimura S, Aoki K, Bhang HC, Bassalleck B, Botta E, Bufalino S, Chiga N, Evtoukhovitch P, Feliciello A, Fujioka H, Hiruma F, Honda R, Hosomi K, Ichikawa Y, Ieiri M, Igarashi Y, Imai K, Ishibashi N, Ishimoto S, Itahashi K, Iwasaki R, Joo CW, Kim MJ, Kim SJ, Kiuchi R, Koike T, Komatsu Y, Kulikov VV, Marcello S, Masumoto S, Matsuoka K, Miwa K, Moritsu M, Nagae T, Naruki M, Niiyama M, Noumi H, Ozawa K, Saito N, Sakaguchi A, Sako H, Samoilov V, Sato M, Sato S, Sato Y, Sawada S, Sekimoto M, Sugimura H, Suzuki S, Takahashi H, Takahashi T, Tamura H, Tanaka T, Tanida K, Tokiyasu AO, Tomida N, Tsamalaidze Z, Ukai M, Yagi K, Yamamoto TO, Yang SB, Yonemoto Y, Yoon CJ, Yoshida K. Search for the Θ+ pentaquark via the π(-)p→K(-)X reaction at 1.92 GeV/c. PHYSICAL REVIEW LETTERS 2012; 109:132002. [PMID: 23030084 DOI: 10.1103/physrevlett.109.132002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/15/2012] [Indexed: 06/01/2023]
Abstract
The Θ(+) pentaquark baryon was searched for via the π(-)p→K(-)X reaction with a missing mass resolution of 1.4 MeV/c(2) (FWHM) at the Japan Proton Accelerator Research Complex (J-PARC). π(-) meson beams were incident on the liquid hydrogen target with a beam momentum of 1.92 GeV/c. No peak structure corresponding to the Θ(+) mass was observed. The upper limit of the production cross section averaged over the scattering angle of 2° to 15° in the laboratory frame is obtained to be 0.26 μb/sr in the mass region of 1.51-1.55 GeV/c(2). The upper limit of the Θ(+) decay width is obtained to be 0.72 and 3.1 MeV for J(Θ)(P)=1/2(+) and J(Θ)(P)=1/2(-), respectively, using the effective Lagrangian approach.
Collapse
|
45
|
Futatsukawa K, Beckford B, Bydžzovsky′ P, Fujibayashi T, Fujii Y, Hashimoto O, Han Y, Hirose K, Hosomi K, Iguchi A, Ishikawa T, Kanda H, Kaneta M, Kawama D, Kawasaki T, Kiyokawa S, Koike T, Konno O, Maeda K, Maruyama N, Miwa K, Miyagi Y, Nakamura S, Sasaki A, Shirotori K, Sotona M, Suzuki K, Tamae T, Tamura H, Terada N, Tsukada K, Yamazaki H. Kaon photoproduction on the deuteron at Sendai. EPJ WEB OF CONFERENCES 2012. [DOI: 10.1051/epjconf/20122002005] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
46
|
Maruo T, Saitoh Y, Hosomi K, Kishima H, Hirata M, Oshino S, Tani N, Morris S, Harada Y, Yoshimine T. PTMS42 The consecutive effect of repetitive transcranial magnetic stimulation (rTMS) on motor and non-motor symptoms of Parkinson's disease. Clin Neurophysiol 2011. [DOI: 10.1016/s1388-2457(11)60695-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
47
|
Hosomi K, Saitoh Y, Kishima H, Oshino S, Hirata M, Tani N, Maruo T, Yoshimine T. PTMS21 Cortical excitability changes in high-frequency repetitive transcranial magnetic stimulation for central post-stroke pain. Clin Neurophysiol 2011. [DOI: 10.1016/s1388-2457(11)60674-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
48
|
Hirata M, Goto T, Yanagisawa T, Inui M, Tamura H, Saitoh Y, Hosomi K, Maruo T, Shayne M, Yorifuji S, Yoshimine T. S16-2 Neurophysiological approach to language function based on event-related oscillatory changes: from functional mapping to brain-machine interface. Clin Neurophysiol 2010. [DOI: 10.1016/s1388-2457(10)60117-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
49
|
Hirata M, Goto T, Yanagisawa T, Inui M, Tamura S, Kishima H, Saitoh Y, Shayne M, Hosomi K, Maruo T, Yorifuji S, Yoshimine T. S36-5 Event-related oscillatory changes: a key to elucidating neural processes. Clin Neurophysiol 2010. [DOI: 10.1016/s1388-2457(10)60226-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
50
|
Hosomi K, Okuno A, Umetani Y, Araya T, Matsuyama K, Haginaka J, Mifune M, Saito Y. Coloration of phenothiazines with metal-containing drugs. YAKUGAKU ZASSHI 2004; 124:587-98. [PMID: 15340180 DOI: 10.1248/yakushi.124.587] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
We studied the color change of phenothiazines and metal-containing drugs after compound formation, followed by use of FT-Raman spectrocopy to observe any structural changes in them. When 6 phenothiazines (thioridazine hydrochloride, prochlorperazine maleate, levomepromazine maleate, chlorpromazine phenolphthalinate, fluphenazine maleate and perphenazine fendiate) formed compounds with natural aluminum silicate, the color change was accompanied by a shift of FT-Raman signals. These changes could be attributed to the structural changes of phenothiazines. This present observation can be then used in advance to avoid coloration of phenothiazines during preparative procedures with metal-containing drugs such as antacids.
Collapse
|